346 related articles for article (PubMed ID: 18194098)
21. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia].
Briceño DF; Correa A; Valencia C; Torres JA; Pacheco R; Montealegre MC; Ospina D; Villegas MV;
Biomedica; 2010; 30(3):371-81. PubMed ID: 21713339
[TBL] [Abstract][Full Text] [Related]
23. The continuing crisis in antibiotic resistance.
French GL
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S3-7. PubMed ID: 21129629
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance in internal medicine wards.
Menichetti F; Tagliaferri E
Intern Emerg Med; 2012 Oct; 7 Suppl 3():S271-81. PubMed ID: 23073868
[TBL] [Abstract][Full Text] [Related]
25. Approaches to reduce antibiotic resistance in the community.
Cohen R
Pediatr Infect Dis J; 2006 Oct; 25(10):977-80. PubMed ID: 17006310
[TBL] [Abstract][Full Text] [Related]
26. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
[TBL] [Abstract][Full Text] [Related]
27. [Short-course antibiotic regimens: Up-to-date].
Dinh A; Bouchand F; Salomon J; Bernard L
Rev Med Interne; 2016 Jul; 37(7):466-72. PubMed ID: 26775641
[TBL] [Abstract][Full Text] [Related]
28. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
[TBL] [Abstract][Full Text] [Related]
29. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
[TBL] [Abstract][Full Text] [Related]
30. Rising bacterial resistance to common antibiotics in Al Ain, United Arab Emirates.
Al-Kaabi MR; Tariq WU; Hassanein AA
East Mediterr Health J; 2011 Jun; 17(6):479-84. PubMed ID: 21796964
[TBL] [Abstract][Full Text] [Related]
31. Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage.
Chen LY; Chen TC; Chen YH; Lin CY; Lin WR; Lu PL
J Microbiol Immunol Infect; 2011 Oct; 44(5):352-7. PubMed ID: 21524975
[TBL] [Abstract][Full Text] [Related]
32. [Completing a course of drug therapy is necessary to combat the infection, not to discourage emergence of resistance].
van der Meer JW; Natsch S
Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1720-2. PubMed ID: 15468900
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of the ESKAPE pathogens.
Pendleton JN; Gorman SP; Gilmore BF
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of bacterial resistance to antimicrobial agents.
Stratton CW
J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial drug resistance in Taiwan.
Huang YT; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S174-8. PubMed ID: 19013350
[TBL] [Abstract][Full Text] [Related]
36. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial peptides: their physicochemical properties and therapeutic application.
Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
[TBL] [Abstract][Full Text] [Related]
38. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
McDonald LC
Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
[TBL] [Abstract][Full Text] [Related]
39. [Antimicrobial resistance after antibiotic use in animals--impact on human health].
Sundsfjord A; Sunde M
Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2457-61. PubMed ID: 19096469
[TBL] [Abstract][Full Text] [Related]
40. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
